Navigation Links
Golub Capital Provides $29.5 Million GOLD Facility in Support of the Recapitalization of ExtruMed
Date:3/26/2008

NEW YORK, March 26 /PRNewswire/ -- Golub Capital today announced that it has provided a $29.5 million one-loan debt financing (through Golub Capital's proprietary GOLD facility) in support of the recapitalization of ExtruMed, a market leader providing precision tubing solutions to the medical industry. Founded in 1990, and based in Placentia, Calif., ExtruMed's products are used in medical devices and technology serving various therapy areas including cardiology, vascular therapies, endosurgery, neurology, Ob/Gyn and urology. GOLD financings are proprietary Golub Capital One-Loan Debt facilities.

ExtruMed has been owned by Inverness Graham Investments and Wedbush Capital Partners since September 2005. The debt provided by Golub Capital will be used to refinance the company's existing debt and provide a cash dividend to the sponsors.

"We are very excited to have closed our first transaction with two private equity sponsors of the caliber of Inverness Graham and Wedbush Capital. We are pleased that we were able to provide them with the appropriate solution for their financing needs," said Golub Capital Managing Director Charlie Riceman. "ExtruMed is a true leader in its field. We have been extremely impressed with the deep knowledge and experience of the ExtruMed management team and are excited to watch ExtruMed continue to build out its capabilities and grow."

"We are pleased to close our first transaction with Golub Capital. The flexibility in structure and spirit of partnership demonstrated by Golub has contributed to a very efficient process. We are pleased to have them as partners in ExtruMed and look forward to future transactions together." says Scott Kehoe, a Managing Principal at Inverness Graham Investments.

Golub Capital lends to broad range of U.S.-based mid-market companies and initially invests between $5 million and $75 million with additional capital available for growth.

About Golub Capital

Golub Capital is an active provider of GOLD (Golub Capital's One-Loan Debt Facility), senior and subordinated debt, second lien debt, preferred stock, and co-investment equity to middle market companies. The firm is committed to being a value-added and user-friendly partner to owners, senior management and transaction sponsors. With a broad investment mandate and long-term time horizon, Golub Capital has a high level of flexibility in structuring investments. For more information, please visit http://www.golubcapital.com.


'/>"/>
SOURCE Golub Capital
Copyright©2008 PR Newswire.
All rights reserved

Related medicine news :

1. Capital BlueCross Receives Prestigious Brand Excellence Award From The Blue Cross & Blue Shield Association
2. Super Model Cindy Crawford will be Honored at DKMS Linked Against Leukemia Gala on May 7th at Capitale
3. St. Alcuin Montessori School Announces $5 Million Capital Campaign Gift
4. InforMedix Retains Murdock Capital Partners
5. LifeMasters Strengthens Capital Structure with $15 Million in Funding from Existing Investors
6. Avista Capital Partners Enhances Energy Practice With Appointment of Gerhard Kurz
7. HealthpointCapital, LLC Appoints Stephen H. Hochschuler, M.D. as Clinical Advisor
8. MaxLife Fund Corp. and Capital Growth Planning Inc., sign a joint venture agreement
9. Ener1 to Present at February Roth Capital 20th Annual OC Growth Stock Conference
10. CryoCor to Present at Roth Capital Partners 20th Annual OC Growth Stock Conference
11. Boston Scientific Completes Sale of Fluid Management and Venous Access Businesses to Avista Capital Partners
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:12/7/2016)... ... OCTOBER XX, 2016 (PRWEB) (PRWEB) December 07, 2016 ... ... A new study entitled “Canine Filamentous Dermatitis Associated with Borrelia Infection” ... dogs. The study was published in the prestigious Journal of Veterinary Science & ...
(Date:12/7/2016)... ... ... Delete® - Tattoo Removal and Laser Salon Offers Delightful Holiday Deals On ... 33% Off Botox® and Juvederm® Products Now Through December 31, 2016 , Delete® - ... on Botox® and Juvederm® just in time for the holiday party season. , ...
(Date:12/7/2016)... ... December 07, 2016 , ... "ProBrand Flip allows FCPX editors ... said Christina Austin - CEO of Pixel Film Studios. , ProBrand Flip includes 30 ... drop zones. Editors can select from a variety of flip book animations. In Addition, ...
(Date:12/7/2016)... (PRWEB) , ... December 07, 2016 , ... “The Road ... is an everyday trial, not a one hour a week showing of hands. “The ... businessman. , Tom begins, “Perhaps you are familiar with the brass ring that you ...
(Date:12/7/2016)... ... (PRWEB) December 07, 2016 , ... ... individuals impacted by cerebral cavernous angiomas, was awarded a grant from the Julian ... engagement program. New Mexico has more people with cavernous angioma than anywhere in ...
Breaking Medicine News(10 mins):
(Date:12/6/2016)...  Licenders is bringing their 100% all-natural lice removal service to ... at 203 13 th Street was specifically chosen to make ... "Our goal is to ease parents, stress and bring their ... children right back to class without skipping a beat. The best ... for the whole family," Licenders President Adie Horowitz states. ...
(Date:12/6/2016)... Dec. 6, 2016 Radioisotopes are radioactive isotopes ... produced either by using nuclear research reactor or by ... of alpha, beta or gamma when changed to a ... in Nuclear medicine, specifically in medical diagnostics. In this ... about a human body,s functioning. Radiotherapy is also used ...
(Date:12/6/2016)... -- Anaplastic Oligoastrocytoma - Pipeline Review, H2 2016 ... and Healthcare disease pipeline guide Anaplastic Oligoastrocytoma – ... the Anaplastic Oligoastrocytoma (Oncology) pipeline landscape. Anaplastic ... two types of cells in the brain, called ... form a mass. These brain cells are known ...
Breaking Medicine Technology: